stockrow
Friday 6 November 2026
Export OPTH’s income statement to Excel — free account
Optimi Health Corp.
OPTH Healthcare Drug Manufacturers Specialty & Generic
Optimi Health Corp.’s revenue for fiscal 2025 (year ended September 2025) was $304,800.00, up 6.39% from fiscal 2024.
2.29
0.08
+3.62%
Follow OPTH
Alert me
Optimi Health Corp. (OPTH) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AYTU Aytu BioPharma, Inc. compare | n/m |
| TXMD TherapeuticsMD, Inc. compare | n/m |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. compare | n/m |
| BFRI Biofrontera Inc. compare | n/m |
| UPC Universe Pharmaceuticals INC compare | n/m |
| SNOA Sonoma Pharmaceuticals, Inc. compare | n/m |
| INM InMed Pharmaceuticals Inc. compare | n/m |
| CPHI China Pharma Holdings, Inc. compare | n/m |
| OPTH Optimi Health Corp. | — |
| Drug Manufacturers Specialty & Generic industry median | 20.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)